Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma

Neurology. 2016 Jul 5;87(1):114-5. doi: 10.1212/WNL.0000000000002810. Epub 2016 Jun 1.

Authors

Aurelio Hernandez-Lain¹, Amaya Hilario², Juan Manuel Sepulveda², Diana Cantero², Ana Ramos², Angel Perez-Nuñez²

Affiliations

¹ From Hospital Universitario 12 de Octubre, Madrid, Spain. aurelio.hlain@salud.madrid.org.
² From Hospital Universitario 12 de Octubre, Madrid, Spain.

PMID: 27251883
DOI: 10.1212/WNL.0000000000002810

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents, Alkylating / administration & dosage
Antineoplastic Agents, Alkylating / pharmacology*
Brain Neoplasms / diagnostic imaging*
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology
Brain Neoplasms / surgery
Dacarbazine / administration & dosage
Dacarbazine / analogs & derivatives*
Dacarbazine / pharmacology
Diffusion Magnetic Resonance Imaging
Disease Progression
Female
Humans
Isocitrate Dehydrogenase / genetics
Male
Middle Aged
Oligodendroglioma / diagnostic imaging*
Oligodendroglioma / drug therapy*
Oligodendroglioma / pathology
Oligodendroglioma / surgery
Temozolomide

Substances

Antineoplastic Agents, Alkylating
Dacarbazine
Isocitrate Dehydrogenase
IDH1 protein, human
Temozolomide